paediatric population

Bharat Biotech’s Covid-19 vaccine — Covaxin — has reported higher neutralising antibodies in children and on an average, it was 1.7 times higher than in adults. The vaccine was well-tolerated and immunogenic in paediatric subjects in Phase II/III study. The study has been accepted and published in Lancet Infectious Diseases. Covaxin is one of the … Read more